## Abstract This article is a condensation of several chapters from __Principles of Therapeutic Change That Work__ edited by L.G. Castonguay and L.E. Beutler. The authors present the work of M.G. Newman, W.B. Stiles, A. Janeck, and S.R. Woody (2006), who outline an integrative model for effective p
Therapeutic factors in dysphoric disorders
โ Scribed by Larry E. Beutler; Louis G. Castonguay; William C. Follette
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 94 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0021-9762
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The working group on the treatment of dysphoric disorders focused on ways to integrate variables and qualities that optimize treatment effects for this clinical population. The variables examined represent three aspects or domains of the treatment context that effect positive change. These included aspects of the patient and therapist (participant factors), those relating to the development and role of the therapeutic relationship (relationship factors), and those that defined the application of formal interventions that are implemented by the therapist (techniques factors). The treatment literature on dysphoric populations was reviewed and a variety of relationships was identified, which then were translated into principles that are thought to enhance treatment effects. The principles representing the three domains of this review are then collected, in this article, into a set of cohesive suggestions for treating patients whose problems are characterized by major or minor depression, alone or as a comorbid condition. ยฉ 2006 Wiley Periodicals, Inc. J Clin Psychol 62: 639โ647, 2006.
๐ SIMILAR VOLUMES
## Objective Premenstrual dysphoric disorder (PMDD) is a mood disorder disrupting social and/or occupational life of affected women. Premenstrual dysphoric disorder etiology is unknown, although a pivotal role is played by the serotoninergic system. Indeed, one of the most effective treatments is s
The feasibility of gene therapy for cardiovascular diseases related to atherosclerosis is a topic that needs to be addressed. Most recent papers have dealt with technical aspects and feasibility and most of the genes transferred were reporter genes like those for 13-galactosidase or luciferase. This